FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
Conventional ocular drug delivery system i.e., eye drops, ointments, gels etc., had become less popular pertaining to their disadvantages like evaporation by tears, pre-corneal loss, drug metabolism, drug-protein interaction, drainage, sticking of eye lids, induced lacrimation, poor patient compliance, systemic side effect and blurred vision etc. That’s why fundamentals of controlled release by means of ocular inserts were utilized to increase problem pre-corneal drug residence time.
This project title “Formulation and Evaluation of Ocuserts of Ciprofloxacin HCl” revealed following results:
Compatibility study using FTIR was performed to check the compatibility of drug with various excipient. Characteristics peaks obtained with pure drug were compared with that produced with different excipients that confirmed the compatibility of drug with excipients.
Ocusert of Ciprofloxacin HCl was prepared using different material i.e., PVP K-30, PVA, PEG 400 and glycerin.
Prepared ocuserts were evaluated for various parameters viz., percentage moisture loss, percentage moisture absorbs, thickness, weight variation, drug content and In-vitro diffusion.
The percentage (%) moisture absorption and loss of ocular insert were found to be 26% and 27% respectively.
The thickness of ocular insert was found to be uniformed and its mean while measuring at different points was found to be 0.124mm.
The weight of ocular inserts was found to be in the range of 12.2 - 12.6mg which indicated decent distribution of the drug, polymer and plasticizer.
The drug content of ocular insert was found to be 99.89%.
Percentage drug release from Ciprofloxacin HCl Ocusert was found to be 41.969% in 8 hr.
It was concluded that prepared Ocusert of Ciprofloxacin HCl could be a better alternative to conventional ocular formulations that retained on ocular surface for longer duration and released drug in controlled manner.
Barrier of drugs permeation through ocular route by Sushil Kumar SinghSushil Singh
Barriers of Drugs Permeation Through Ocular Route. this topic explain about ocular route and barriers system. and classification of different injection routes takes the ocular drugs.
The presentation includes Introduction to Ocular Drug Delivery System, Anatomy of Human eye, Mechanism of Ocular Drug Absorption, Barriers for Ocular Delivery, Factors affecting Intraocular bioavailability, Drawbacks of traditional ophthalmic formulations, Classification of Ocular Drug Delivery System, Formulations of Ocular Drug Delivery System and Evaluation parameters of Ocular Drug Delivery System.
Contents
Introduction
Objective
Anatomy of the Eye
Routes of drug delivery of the eye
Mechanism of ocular absorption
Factors affecting intra-ocular bioavailability
Barriers of ocular drug absorption
Methods to overcome drug barriers
Evaluation
Conclusion
Reference
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Applied topically to the cornea, or instilled in the space between the eyeball and lower eyelid
Definition: Ocular DDS are designed to instilled on to topical or intra-ocular or peri-ocular to eye.
Most commonly used ocular dosage forms-
- Solutions
- Suspensions
- ointments
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
Conventional ocular drug delivery system i.e., eye drops, ointments, gels etc., had become less popular pertaining to their disadvantages like evaporation by tears, pre-corneal loss, drug metabolism, drug-protein interaction, drainage, sticking of eye lids, induced lacrimation, poor patient compliance, systemic side effect and blurred vision etc. That’s why fundamentals of controlled release by means of ocular inserts were utilized to increase problem pre-corneal drug residence time.
This project title “Formulation and Evaluation of Ocuserts of Ciprofloxacin HCl” revealed following results:
Compatibility study using FTIR was performed to check the compatibility of drug with various excipient. Characteristics peaks obtained with pure drug were compared with that produced with different excipients that confirmed the compatibility of drug with excipients.
Ocusert of Ciprofloxacin HCl was prepared using different material i.e., PVP K-30, PVA, PEG 400 and glycerin.
Prepared ocuserts were evaluated for various parameters viz., percentage moisture loss, percentage moisture absorbs, thickness, weight variation, drug content and In-vitro diffusion.
The percentage (%) moisture absorption and loss of ocular insert were found to be 26% and 27% respectively.
The thickness of ocular insert was found to be uniformed and its mean while measuring at different points was found to be 0.124mm.
The weight of ocular inserts was found to be in the range of 12.2 - 12.6mg which indicated decent distribution of the drug, polymer and plasticizer.
The drug content of ocular insert was found to be 99.89%.
Percentage drug release from Ciprofloxacin HCl Ocusert was found to be 41.969% in 8 hr.
It was concluded that prepared Ocusert of Ciprofloxacin HCl could be a better alternative to conventional ocular formulations that retained on ocular surface for longer duration and released drug in controlled manner.
Barrier of drugs permeation through ocular route by Sushil Kumar SinghSushil Singh
Barriers of Drugs Permeation Through Ocular Route. this topic explain about ocular route and barriers system. and classification of different injection routes takes the ocular drugs.
The presentation includes Introduction to Ocular Drug Delivery System, Anatomy of Human eye, Mechanism of Ocular Drug Absorption, Barriers for Ocular Delivery, Factors affecting Intraocular bioavailability, Drawbacks of traditional ophthalmic formulations, Classification of Ocular Drug Delivery System, Formulations of Ocular Drug Delivery System and Evaluation parameters of Ocular Drug Delivery System.
Contents
Introduction
Objective
Anatomy of the Eye
Routes of drug delivery of the eye
Mechanism of ocular absorption
Factors affecting intra-ocular bioavailability
Barriers of ocular drug absorption
Methods to overcome drug barriers
Evaluation
Conclusion
Reference
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Applied topically to the cornea, or instilled in the space between the eyeball and lower eyelid
Definition: Ocular DDS are designed to instilled on to topical or intra-ocular or peri-ocular to eye.
Most commonly used ocular dosage forms-
- Solutions
- Suspensions
- ointments
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
TYPES OF OPTHALMIC PRODUCTS
Eye drops - Ophthalmic drops (eye drops) are sterile aqueous or oily solutions, suspensions, or emulsions intended for instillation into the conjunctival sac. Ophthalmic drops are considered isotonic when the tonicity is equal to that of a 0.9% solution of sodium chloride.
Eye lotion – Eye lotions are the aqueous solutions used for washing the eyes. The eye lotions are supplied in concentrated form and are required to be diluted with warm water immediately before use.
v
Eye Ointments - Ophthalmic ointments are sterile, homogeneous, semi-solid preparations intended for application to the conjunctiva or the eyelids. They are
What is Artificial Intelligence | Artificial Intelligence Tutorial For Beginn...Edureka!
** Machine Learning Engineer Masters Program: https://www.edureka.co/masters-program/machine-learning-engineer-training **
This tutorial on Artificial Intelligence gives you a brief introduction to AI discussing how it can be a threat as well as useful. This tutorial covers the following topics:
1. AI as a threat
2. What is AI?
3. History of AI
4. Machine Learning & Deep Learning examples
5. Dependency on AI
6.Applications of AI
7. AI Course at Edureka - https://goo.gl/VWNeAu
For more information, please write back to us at sales@edureka.co
Call us at IN: 9606058406 / US: 18338555775
Facebook: https://www.facebook.com/edurekaIN/
Twitter: https://twitter.com/edurekain
LinkedIn: https://www.linkedin.com/company/edureka
it is a complete overview on ophthalmic dosage form. beginning from anatomy and physiology of eye with drug absorption mechanism including all factors to formulation considerations and evaluation of the products i.e. eye drops and eye ointment & the evaluation tests. it will help you make the concepts clear about ophthalmic drug deliveries.
In the area of topical ocular administration, important efforts concern the design and the conception of new ophthalmic drug delivery systems able to prolong the residence time.
Slide 1: Title Slide
- Title: Ocular Drug Delivery Systems:
- Presenter Name and Affiliation
Slide 2: Introduction
- Importance of efficient drug delivery to the eye for the treatment of ocular diseases.
- Challenges with conventional eye drops and the need for improved drug absorption and residence time.
- Objectives of ocular drug delivery systems: enhancing drug bioavailability, prolonging drug release, and providing targeted delivery.
Slide 3: Overview of Ocular Drug Delivery Systems
- Definition of ocular drug delivery systems as specialized techniques and formulations for drug administration to the eye.
- Importance of improving drug delivery to achieve therapeutic efficacy.
- Goals: enhancing drug bioavailability, prolonging drug release, and providing targeted delivery.
Slide 4: Types of Ocular Drug Delivery Systems
- Topical Formulations:
- Eye Drops: Traditional method with limited drug absorption.
- Ointments and Gels: Improved residence time but may cause blurred vision.
- Sprays and Aerosols: Effective for certain medications but challenging for accurate administration.
Slide 5: Types of Ocular Drug Delivery Systems (continued)
- Solid Drug Delivery Systems:
- Inserts and Implants: Sustained release of drugs over an extended period.
- Microparticles and Nanoparticles: Enhanced drug stability, bioavailability, and targeted delivery.
Slide 6: Types of Ocular Drug Delivery Systems (continued)
- Contact Lenses:
- Drug-Eluting Lenses: Act as reservoirs to release drugs gradually.
- Mucoadhesive Lenses: Improve drug retention and bioavailability.
Slide 7-45: Advantages of Ocular Drug Delivery Systems
- Increased Bioavailability: Enhanced drug absorption and residence time for improved therapeutic efficacy.
- Targeted Delivery: Localized treatment of ocular tissues, minimizing systemic side effects.
- Prolonged Drug Release: Controlled release systems reduce the frequency of administration.
- Patient Compliance: Convenience and ease of use improve patient adherence to treatment regimens.
Slide 46: Challenges and Future Perspectives
- Barrier Properties: Overcoming the ocular barriers for effective drug penetration.
- Biocompatibility: Ensuring the drug delivery system is well-tolerated by ocular tissues.
- Manufacturing and Regulatory Considerations: Meeting quality standards and regulatory requirements for commercial production.
- Future Developments: Nanotechnology, biomaterials, and gene therapy for advancing ocular drug delivery systems.
Slide 47: Conclusion
- Recap of the importance of ocular drug delivery systems for improving treatment outcomes.
- Potential benefits of enhanced drug bioavailability, targeted delivery, and prolonged drug release.
- Acknowledgment of challenges and the promising future of ocular drug delivery systems.
Slide 48: Thank You
- Contact
INTRODUCTION :
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Eye is the most easily accessible site for topical administration of a medication.
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
The bioavailability of ophthalmic drugs is very poor due to efficient protective mechanisms of the eye.
Blinking, reflex lachrymation, and drainage rapidly remove drugs, from the surface of the eye.
To overcome these, two approaches can be followed.
The first involves using alternate delivery routes to conventional ones allowing for more direct access to intended target sites.
Second approach involves development of novel drug delivery systems providing better permeability, treatability and controlled release at target site.
Combination of both these approaches are being utilized and optimized in order to achieve optimal therapy with minimal adverse effects.
Introduction
Anatomy and physiology of human eye
Ocular delivery system
Optimum characters of ophthalmic drugs
Routes of ophthalmic drugs
Mechanism of ocular drug absorption
Barriers and fate of ocular drug delivery
Formulation consideration of ocular dosage forms
Evaluation tests
References
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. Agenda...
• Objective
• Introduction
• Anatomy and physiology of the eye
• Mechanism of ocular absorption
• Factors affecting intraocular bioavailability
• Approaches to improve ocular drug delivery
• Classification of ocular drug delivery systems
• Non erodible inserts
• Erodible inserts
• Control delivery systems
• Conclusion
2OCULAR DDS
3. To review and study ocular drug delivery system.
To study various factors affecting ocular
absorption.
To know various approaches ot improve drug
absorption.
To study mechanism of drug absorption.
3OCULAR DDS
4. Definition
They are specialized dosage forms designed to be instilled onto the
external surface of the eye (topical), administered inside
(intraocular) or adjacent (periocular) to the eye or used in
conjunction with an ophthalmic device.
The most commonly employed ophthalmic dosage forms are
solutions, suspensions, and ointments.
But these preparations when instilled into the eye are rapidly
drained away from the ocular cavity due to tear flow and lacrimal
nasal drainage.
4OCULAR DDS
5. Ocular administration of drug is primarily associated with the need
to treat ophthalmic diseases.
Eye is the most easily accessible site for topical administration of a
medication.
Ideal ophthalmic drug delivery must be able to sustain the drug
release and to remain in the vicinity of front of the eye for prolong
period of time.
The newest dosage forms for ophthalmic drug delivery are: gels, gel-
forming solutions, ocular inserts , intravitreal injections and
implants.
5OCULAR DDS
6. Major classes of drugs used are
Miotics e.g. pilocarpine Hcl
Mydriatics e.g. atropine
Cycloplegics e.g. atropine
Anti-inflammatories e.g. corticosteroids
Anti-infectives (antibiotics, antivirals and antibacterials)
Anti-glucoma drugs e.g. pilocarpine Hcl
Surgical adjuncts e.g. irrigating solutions
Diagnostic drugs e.g. sodiumfluorescein
Anesthetics e.g. tetracaine 6OCULAR DDS
7. Water - 98%,
Solid -1.8%,
Organic element
Protein - 0.67%,
sugar - 0.65%,
NaCl - 0.66%
Other mineral element
sodium, potassium and ammonia - 0.79%.
7OCULAR DDS
9. Human eye
Diameter 23 mm
Structure comprises of three layers
1. Outermost coat : The clear, transparent cornea and the
white, opaque sclera
2. Middle layer : The iris anteriorly, the choroid posteriorly,
and the ciliary body at the intermediate part
3. Inner layer : Retina (extension of CNS)
Cornea
Epithelium-stroma-endothelium
(fat-water-fat structure)
Penetration of the drug depends on Oil-water partition
coefficient
9OCULAR DDS
11. Fluid systems in eye
1. Aqueous humor
Secreted from blood through epithelium of the ciliary body.
Secreted in posterior chamber and transported to anterior
chamber.
2. Vitreous humor
Secreted from blood through epithelium of the ciliary body.
Diffuse through the vitreous body.
Lacrimal glands
Secrete tears & wash foreign bodies.
Moistens the cornea from drying out.
11OCULAR DDS
12. The sclera : The protective outer layer of the eye, referred to as the
“white of the eye” and it maintains the shape of the eye.
The cornea : The front portion of the sclera, is transparent and allows
light to enter the eye. The cornea is a powerful refracting surface,
providing much of the eye's focusing power.
The choroid : is the second layer of the eye and lies between the
sclera and the retina. It contains the blood vessels that provide
nourishment to the outer layers of the retina.
The iris : is the part of the eye that gives it color. It consists of muscular
tissue that responds to surrounding light, making the pupil, or circular
opening in the center of the iris, larger or smaller depending on the
brightness of the light. 12OCULAR DDS
13. The lens is a transparent, biconvex structure, encased in a thin
transparent covering. The function of the lens is to refract and
focus incoming light onto the retina.
The retina is the innermost layer in the eye. It converts images into
electrical impulses that are sent along the optic nerve to the brain
where the images are interpreted.
The macula is located in the back of the eye, in the center of the
retina. This area produces the sharpest vision.
13OCULAR DDS
14. Non-Corneal
Absorption
• Penetration across Sclera & Conjuctiva into Intra Ocular tissues
• Non-Productive: because penetrated drug is absorbed by general
circulation
Corneal
Absorption
• Outer Epithelium: rate limiting barrier, with pore size 60å,Only
access to small ionic & lipohilic molecules
• Trans cellular transport: transport between corneal epithelium &
stroma.
14OCULAR DDS
16. Includes-
• Pre corneal
• Corneal
• Interior of the eye
1. Inflow & outflow of lacrimal fluids.
2. Efficient naso-lacrimal drainage.
3. Interaction of drug with proteins of lacrimal fluid.
4. Dilution with tears.
5. Corneal barriers
6. Physico-chemical properties of drugs
7. Active ion transport at cornea,
8. Limited and poor corneal permeability
9. Metabolism
16OCULAR DDS
17. Factors affecting drug availability:
1. Rapid solution drainage by gravity, induced lachrymation,
blinking reflex, and normal tear turnover.
The normal volume of tears = 7 ul,
The blinking eye can accommodate a volume of up to 30
ul without spillage,
The drop volume = 50 ul
2. Superficial absorption of drug into the conjunctiva and
sclera and rapid removal by the peripheral blood flow
17OCULAR DDS
18. 3. Low corneal permeability (act as lipid barrier)
In general:
- Transport of hydrophilic and macromolecular drugs
occurs through scleral route.
- Lipophilic agents of low molecular weight follow
transcorneal transport by passive diffusion.
4. Metabolism
Enzymatic biotransformation
Esterases, oxidoreductases, Peptidases, Glucuronide
Sulfate transferases, Lysosomal enzymes
18OCULAR DDS
20. 1. Viscosity enhancers
2. Eye ointments
3. Gel
4. Prodrug
5. Penetration enhancers
6. Liposomes
7. Niosomes
8. Nanosuspension
9. Microemulsion
10. Nanoparticles/nanospheres
11. In situ-forming gel
20OCULAR DDS
21. Enhancement of bioavailability
1. Increase in viscosity of formulation leads to decrease in drainage.
2. Slows elimination rate from the precorneal area and enhance contact
time.
3. Generally hydrophilic polymers, eg. Methyl cellulose, polyvinyl
alcohols, polyacrylic acids, sodium carboxy methyl cellulose,
carbomer is used.
4. A minimum viscosity of 20 cst is needed for optimum corneal
absorption.
21OCULAR DDS
22. Use of penetration enhancers
1. Act by increasing corneal uptake by modifying the integrity of the
corneal epithelium.
2. Substances which increases the permeability characteristics of the
cornea by modifying the integrity of corneal epithelium are known
as penetration enhancers.
Modes of actions
1. By increasing the permeability of the cell membrane.
2. Acting mainly on tight junctions.
e.g. Caprylic acid, sodium caprate, Azone
22OCULAR DDS
23. PRODRUGS
1. Prodrugs enhance corneal drug permeability through
modification of the hydrophilic or lipophilicity of the drug.
2. The method includes modification of chemical structure of the
drug molecule, thus making it selective, site specific and a safe
ocular drug delivery system.
3. Drugs with increased penetrability through prodrug
formulations are epinehrine, phenylephrine, timolol,
pilocarpine.
23OCULAR DDS
24. USE OF MUCOADHESIVES IN OCULAR DRUG
DELIVERY
1. Polymereric mucoadhesive vehicle: Retained in the eye due to
noncovalent bonding with conjuctival mucine.
2. Mucine is capable of picking of 40-80 times of weight of water.
3. Thus prolongs the residence time of drug in the conjuctival sac.
4. Mucoadhesives contain the dosage form which remains adhered to
cornea until the polymer is degraded or mucus replaces itself.
Types
1. Naturally Occurring Mucoadhesives - Lectins, Fibronectins
2. Synthetic Mucoadhesives - PVA,Carbopol, carboxy methyl cellulose,
cross-linked polyacrylic acid.
24OCULAR DDS
25. Phase Transition System
1. Solution that are liquid in the container and thus can be instilled
as eye drop becomes gel on contact with the tear fluid and
provide increased contact time with the possibility of improved
drug absorption and increased duration of therapeutic effect.
2. Liquid-gel phase transition-dependent delivery system vary
according to the particular polymer employed and their
mechanism for triggering the transition to a gel phase in the eye
take advantage of change in temperature, pH, ion sensitivity, or
lysozymes upon contact with tear fluid.
25OCULAR DDS
26. POLYMER MECHANISM
Lutrol FC – 127 and Poloxamer 407 Viscosity increased when their
temperature raised to eye
temperature.
Cellulose acetate phthalate latex Coagulates when its native pH 4.5
raised by tear fluid to pH 7.4
Gelrite Forms clear gel in the presence of
cations
EXAMLE OF POLYMER
26OCULAR DDS
27. OCULAR DELIVERY
SYSTEMS
CONVENTIONAL VESICULAR
CONTROL RELEASE PARTICULATE
o IMPLANTS
o HYDROGELS
o DENDRIMERS
o IONTOPORESIS
o COLLAGEN SHIELD
o POLYMERIC
SOLUTIONS
o CONTACT LENSES
o CYCLODEXRIN
o MICROONEEDLE
o MICROEMULSIONS
o NANO
SUSPENSION
o MICROPARTICLES
o NANOPARTICLES
o LIPOSOMES
o NIOSOMES
o DISCOMES
o PHARMACOSOMES
ADVANCED
o SCLERAL PLUGS
o GENE DELIVERY
o Si RNA
o STEM CELL
o SOLUTION
o SUSPENSION
o EMULSION
o OINTMENT
o INSERT
o GELS
27OCULAR DDS
29. Good corneal penetration.
Prolong contact time with corneal tissue.
Simplicity of instillation for the patient.
Non irritative and comfortable form.
Appropriate rheological properties.
Inert and stable.
29OCULAR DDS
30. Eye Drops
o Drugs which are active at eye or eye surface are widely
administered in the form of Solutions, Emulsion and Suspension.
o Various properties of eye drops like hydrogen ion concentration,
osmolality, viscosity and instilled volume can influence retention of
a solution in the eye.
o Less than 5 % of the dose is absorbed after topical administration
into the eye.
o The dose is mostly absorbed to the systemic blood circulation via
the conjunctival and nasal blood vessels.
30OCULAR DDS
31. Advantages And Disadvantages Of Eye Drops
Dosage form Advantages Disadvantages
Solutions 1. Convenience
2. Usually do not interfere
with vision of patient.
1. Rapid precorneal elimination.
2. Non sustained action.
3. To be Administered at frequent
intervals.
Suspension 1. Patient compliance.
2. Best for drug with slow
dissolution.
3. Longer contact time
1. Drug properties decide
performance loss of both solutions
and suspended particles.
2. Irritation potential due to the
particle size of the drug.
Emulsion 1. Prolonged release of drug
from vehicle
1. Blurred vision.
2. patient non compliance.
31OCULAR DDS
32. • Prolongation of drug contact time with the external ocular surface
can be achieved using ophthalmic ointment vehicle.
• The ointment base is sterilized by heat and appropriately filtered
while molten to remove foreign particulate matter.
Ointment base is
sterilized by heat and
filtered while molten
to remove foreign
particulate matter.
It is then placed into a
sterile steam jacketed
to maintain the
ointment in a molten
state and excipients
are added
The entire ointment
may be passed
through a previously
sterilized colloid mill
32OCULAR DDS
33. • Advantages
1. Longer contact time and greater storage stability.
2. Flexibility in drug choice.
3. Improved drug stability.
• Disadvantages
1. Sticking of eyes lids.
2. Blurred vision.
3. Poor patient compliance
4. Interfere with the attachment of new corneal epithelial cells
to their normal base.
5. Matting of eyelids
33OCULAR DDS
34. • Gels
1. Ophthalmic gels are composed of mucoadhesive polymers that
provide localized delivery of an active ingredient to the eye. Such
polymers have a property known as bioadhesion.
2. These polymers are able to extend the contact time of the drug
with the biological tissues and there by improve ocular
bioavailability.
Advantages
1. Longer contact time.
2. Greater storage stability.
Disadvantages
1. Blurred vision but less then ointment.
2. Poor patient compliance.
34OCULAR DDS
35. Vesicular System
• LIPOSOMES
Liposomes are biocompatible and biodegradable lipid vesicles made
up of natural lipids and about 25 –10 000 nm in diameter.
They are having an intimate contact with the corneal and conjunctival
surfaces which is desirable for drugs that are poorly absorbed, the drugs
with low partition coefficient, poor solubility or those with medium to
high molecular weights and thus increases the probability of ocular drug
absorption.
Vesicle composed of phospholipid bilayer enclosing aqueous
compartment in alternate fashion.
It is Biodegradable, Non-toxic in nature.
35OCULAR DDS
36. Types : 1. MLV
2. ULV-SUV(upto 100 nm)
3. LUV(more than 100 nm)
Polar drugs are incorporated in aqueous compartment while
lipophilic drugs are intercalated into the liposome membrane.
Phospholipids used- Phosphotidylcholine, Phosphotidic acid,
Sphingomyline, Phosphotidyleserine, Cardiolipine.
36OCULAR DDS
37. ADVANTAGES
Drugs delivered intact to
various body tissues.
Liposomes can be used for
both hydrophilic and
hydrophobic drug.
Possibility of targeting and
decrease drug toxicity.
The size, charge and other
characteristics can be altered
according to drug and desired
tissue.
DISADVANTAGES
Their tendency to be
uptaken by RI system.
They need many
modification for drug
delivery to special organs.
Costly.
Stability problem and
oxidative degradation.
Requires special
packaging and storing
facility.
37OCULAR DDS
39. The major limitations of liposomes are chemical instability,
oxidative degradation of phospholipids, cost and purity of natural
phospholipids.
To avoid this niosomes are developed as they are chemically stable
as compared to liposomes and can entrap both hydrophobic and
hydrophilic drugs.
Niosomes are non-ionic surfactant based multilamellar (>0.05µm),
small unilamellar (0.025-0.05µm) or large unilamellar vesicles
(>0.1µm) in which an aqueous solution of solute(s) is entirely
enclosed by a membrane resulted from organization of surfactant
macromolecules as bilayers. 39OCULAR DDS
40. They are non toxic and do not require special handling techniques.
Niosomes are nonionic surfactant vesicles that have potential
applications in the delivery of hydrophobic or amphiphilic drugs.
STRUCTURAL COMPONENTS USED
• Surfactants (dialkyl polyoxy ethylene ether non ionic surfactant)
• Cholesterol.
40OCULAR DDS
41. ADVANTAGES
The vesicle suspension being water based offers greater patient
compliance over oil based systems.
Since the structure of the niosome offers place to accommodate
hydrophilic, lipophilic as well as ampiphilic drug moieties, they can
be used for a variety of drugs.
The characteristics such as size, lamellarity etc. of the vesicle can be
varied depending on the requirement.
The vesicles can act as a depot to release the drug slowly and offer a
controlled release.
41OCULAR DDS
42. They are osmotically active and stable.
They increase the stability of the entrapped drug.
Improves therapeutic performance of the drug by protecting
it from the biological environment and restricting effects to
target cells, thereby reducing the clearance of the drug.
Drawbacks
Physical instability.
Aggregation.
Leaking of entrapped drug.
42OCULAR DDS
43. This term is used for pure drug vesicles formed by the amphiphilic
drugs.
The amphiphilic prodrug is converted to pharmacosomes on dilution
with water.
Since many drugs are also amphiphiles, they can form the vesicles.
Advantages
Drug metabolism can be decreased.
Controled release profile can be achieved.
43OCULAR DDS
44. • Soluble surface active agents when added in critical amount to
vesicular dispersion leads to solubilization or breakdown of vesicles
& translates them into mixed micellar systems
e.g: Egg yolk phosphatidyl choline liposomes by the addition
of non ionic surfactants of poly oxy ethylene cetyl ether till the
lamellar and mixed lamellar coexist
Advantages
• Minimal opacity imposes no hinderance to vision
• Increased patient compliance
• Zero order release can be easily attained
44OCULAR DDS
45. 1. No difficulty of insertion as in the case of ocular inserts.
2. No tissue irritation and damage as caused by penetration enhancers.
3. Provide patient compliance as there is no difficulty of insertion as
observed in the case of inserts.
4. The vesicular carriers are biocompatable and have minimum side effects.
5. Degradation products formed after the release of drugs are
biocompatable.
6. They prevent the metabolism of drugs from the enzymes present at
tear/corneal epithelium interface.
7. Provide a prolong and sustained release of drug.
45OCULAR DDS
47. NON ERODIBLE INSERTS
OCUSERT
The Ocusert therapeutic system is a flat, flexible, elliptical device
designed to be placed in the inferior cul-de-sac between the sclera
and the eyelid and to release Pilocarpine continuously at a steady
rate for 7 days.
The device consists of 3 layers…..
1. Outer layer - ethylene vinyl acetate copolymer layer.
2. Inner Core - Pilocarpine gelled with alginate main polymer.
3. A retaining ring - of EVA impregnated with titanium di oxide
47OCULAR DDS
49. • ADVANTAGES
Reduced local side effects and toxicity.
Around the clock control of drug.
Improved compliance.
• DISADVANTAGES
Retention in the eye for the full 7 days.
Periodical check of unit.
Replacement of contaminated unit
Expensive.
49OCULAR DDS
50. ERODIBLE INSERTS
The solid inserts absorb the aqueous tear fluid and gradually erode
or disintegrate. The drug is slowly leached from the hydrophilic
matrix.
They quickly lose their solid integrity and are squeezed out of the
eye with eye movement and blinking.
Do not have to be removed at the end of their use.
Three types :
1. Lacriserts
2. Sodi
3. Minidisc
50OCULAR DDS
51. • LACRISERTS
Sterile rod shaped device made up of hydroxyl propyl cellulose
without any preservative.
For the treatment of dry eye syndromes.
It weighs 5 mg and measures 1.27 mm in diameter with a
length of 3.5 mm.
It is inserted into the inferior fornix.
• SODI
Soluble ocular drug inserts.
Small oval wafer.
Sterile thin film of oval shape.
Weighs 15-16 mg.
Use – glaucoma.
Advantage – Single application.
Lacriserts
51OCULAR DDS
52. • Minidisc
Countered disc with a convex front and a concave back surface.
Diameter – 4 to 5 mm.
• Composition
Silicone based prepolymer-alpha-w-dis (4-methacryloxy)-butyl poly
di methyl siloxane. (M2DX)
M-Methyl a cryloxy butyl functionalities.
D – Di methyl siloxane functionalities.
Pilocarpine, chloramphenicol.
Minidisc 52OCULAR DDS
53. • Contact lenses can be a way of providing extended
release of drugs into the eye.
• Conventional hydrogel soft contact lenses have the
ability to absorb some drugs and release them into
the post lens lachrymal fluid, minimizing clearance
and sorption through the conjunctiva.
• Their ability to be a drug reservoir strongly
depends on the water content and thickness of the
lens, the molecular weight of the drug, the
concentration of the drug loading solution and the
time the lens remains in it.
53OCULAR DDS
54. Type Advantages Disadvantages
Erodible inserts Effective.
Flexiblility in drug type &
dissolution rate.
Need only be introduced
into eye & not removed.
Patient discomfort.
Requires patient
insertion.
Occasional product.
Non-erodible inserts Controlled rate of release.
Prolonged delivery.
Flexibility for type of drug
selected.
Sustained release.
Patient discomfort.
Irritation to eye.
Tissue fibrosis.
Advantages And Disadvantages Of Ocular Inserts
54OCULAR DDS
55. Control Delivery Systems
1. Implants have been widely employed to extend the release of drugs
in ocular fluids and tissues particularly in the posterior segment.
2. Implants can be broadly classified into two categories based on their
degradation properties:
(1) Biodegradable
(2) Nonbiodegradable
1. With implants, the delivery rate could be modulated by varying
polymer composition.
2. Implants can be solids, semisolids or particulate-based delivery
systems. 55OCULAR DDS
56. For chronic ocular diseases like cytomegalo virus (CMV)
retinitis, implants are effective drug delivery system. Earlier
non biodegradable polymers were used but they needed
surgical procedures for insertion and removal.
Presently biodegradable polymers such as Poly Lactic Acid
(PLA) are safe and effective to deliver drugs in the vitreous
cavity and show no toxic signs.
56OCULAR DDS
57. In Iontophoresis direct current drives ions into cells or tissues. For
iontophoresis the ions of importance should be charged
molecules of the drug.
If the drug molecules carry a positive charge, they are driven into
the tissues at the anode; if negatively charged, at the cathode.
Requires a mild electric current which is applied to enhance
ionized drug penetration into tissue.
Ocular iontophoresis offers a drug delivery system that is fast,
painless, safe, and results in the delivery of a high concentration
of the drug to a specific site.
57OCULAR DDS
58. Ocular iontophoresis delivery is not only fast, painless and safe but
it can also deliver high concentration of the drug to a specific site.
Ocular iontophoresis has gained significant interest recently due to
its non-invasive nature of delivery to both anterior and posterior
segment.
Iontophoretic application of antibiotics may enhance their
bactericidal activity and reduce the severity of disease
Can overcome the potential side effects associated with intraocular
injections and implants.
Iontophoresis is useful for the treatment of bacterial keratitis.
58OCULAR DDS
60. Dendrimer
Dendrimers can successfully used for different routes of drug
administration and have better water-solubility, bioavailability and
biocompatibility.
Microemulsion
Microemulsion is dispersion of water and oil stabilized using
surfactant and co- surfactant to reduce interfacial tension and
usually characterized by small droplet size (100 nm), higher
thermodynamic stability and clear appearance.
Selection of aqueous phase, organic phase and surfactant/co-
surfactant systems are critical parameters which can affect stability
of the system. 60OCULAR DDS
61. Nanosuspensions have emerged as a promising strategy for the
efficient delivery of hydrophobic drugs because they enhanced not
only the rate and extent of ophthalmic drug absorption but also the
intensity of drug action with significant extended duration of drug
effect.
For commercial preparation of nanosuspensions, techniques like
media milling and high-pressure homogenization have been used.
61OCULAR DDS
62. Advance System
• Design of Punctal Plug
1. Punctal plugs are placed in the tear duct (punctum) to
release a variety of drugs.
2. Currently targeting the treatment of glaucoma and ocular
hypertension
OCULAR DDS 62
63. • Design of Replenish Mini Pump
1. Micro-electromechanical system that delivers continuous or
bolus-targeted drugs to both the anterior and posterior
segments.
2. Refillable drug reservoir (via 31 gauge needle) that is
capable of storing and delivering up to 12 months.
OCULAR DDS 63
64. • Design of ODTx
1. Non-biodegradable implant that is comprised of multiple sealed
reservoirs containing individual doses of drugs.
2. Implant is injected into the vitreous.
3. Drug is released by creating an opening via laser.
OCULAR DDS 64
65. • I-vation™
1. A solid triamcinolone acetnoide implant, can delivery up to 24
months.
2. Phase I showed positive outcome, phase 2 was terminated
before completion.
3. Also, has polysaccharide-based matrix for protein delivery
(eureka™ duet)
OCULAR DDS 65
66. • Vitrasert®
1. (Ganciclovir-CMV retinitis) and Retisert® (fluocinolone acetonide-
chronic non infectious uveitis).
2. Are FDA approved
3. These devices are solid sustained-release devices, typically made
of PLGA, capable of delivering drug for up to 30 months.
OCULAR DDS 66